Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20463 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1310] 

Certain Interactive Fitness Products 

Including Stationary Exercise Bikes, 

Treadmills, Elliptical Machines, and 

Rowing Machines and Components 

Thereof; Notice of Institution of 

Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on 

March 3, 2022, under section 337 of the 

Tariff Act of 1930, as amended, on 

behalf of Peloton Interactive, Inc. of 

New York, New York. A supplement to 

the complaint was filed on March 21, 

2022. The complaint, as supplemented, 

alleges violations of section 337 based 

upon the importation into the United 

States, the sale for importation, and the 

sale within the United States after 

importation of certain interactive fitness 

products including stationary exercise 

bikes, treadmills, elliptical machines, 

and rowing machines and components 

thereof by reason of infringement of 

certain claims of U.S. Patent No. 

11,170,886 (‘‘the ’886 Patent’’); U.S. Pat. 

No. 7,938,755 (‘‘the ’755 Patent’’); U.S. 

Patent No. 11,183,288 (‘‘the ’288 

Patent’’); U.S. Patent No. 11,145,399 

(‘‘the ’399 Patent’’); and U.S. Pat. No. 

10,864,406 (‘‘the ’406 patent’’). The 

complaint further alleges that an 

industry in the United States exists as 

required by the applicable Federal 

Statute. The complainant requests that 

the Commission institute an 

investigation and, after the 

investigation, issue a limited exclusion 

order and cease and desist orders. 

ADDRESSES: The complaint, except for 

any confidential information contained 

therein, may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. Hearing impaired 

individuals are advised that information 

on this matter can be obtained by 

contacting the Commission’s TDD 

terminal on (202) 205–1810. Persons 

with mobility impairments who will 

need special assistance in gaining access 

to the Commission should contact the 

Office of the Secretary at (202) 205– 

2000. General information concerning 

the Commission may also be obtained 

by accessing its internet server at 

https://www.usitc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Katherine Hiner, Office of Docket 

Services, U.S. International Trade 

Commission, telephone (202) 205–1802. 

SUPPLEMENTARY INFORMATION:

Authority: The authority for 

institution of this investigation is 

contained in section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, and in section 210.10 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10 (2021). 

Scope of Investigation: Having 

considered the complaint, the U.S. 

International Trade Commission, on 

April 1, 2022, ordered that— 

(1) Pursuant to subsection (b) of 

section 337 of the Tariff Act of 1930, as 

amended, an investigation be instituted 

to determine whether there is a 

violation of subsection (a)(1)(B) of 

section 337 in the importation into the 

United States, the sale for importation, 

or the sale within the United States after 

importation of certain products 

identified in paragraph (2) by reason of 

infringement of one or more of claims 1, 

3–15, 17, 19, 20–22 of the ’886 Patent; 

claims 1, 2, 5–7, 8, 9 of the ’755 Patent; 

claims 1, 2–24, 25, 26–29 of the ’288 

Patent; claims 1, 2–3, 5–13, 16–17, 19– 

20, 21, 22–28 of the ’399 Patent; and 

claims 11, 12, 14, 15, 16 of the ’406 

Patent, and whether an industry in the 

United States exists as required by 

subsection (a)(2) of section 337; 

(2) Pursuant to section 210.10(b)(1) of 

the Commission’s Rules of Practice and 

Procedure, 19 CFR 210.10(b)(1), the 

plain language description of the 

accused products or category of accused 

products, which defines the scope of the 

investigation, is ‘‘stationary bikes, 

treadmills, elliptical machines, and 

rowing machines used with interactive 

fitness programs or containing an air 

dam’’; 

(3) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainant is: Peloton 

Interactive, Inc., 441 9th Avenue, 6th 

Floor, New York, NY 10001. 

(b) The respondents are the following 

entities alleged to be in violation of 

section 337, and are the parties upon 

which the complaint is to be served: 

ICON Fitness Corp., 1500 South 1000 

West, Logan, UT 84321 

IHF Holdings Inc., 1500 South 1000 

West, Logan, UT 84321 

iFIT Inc. (FKA ICON Health & Fitness, 

Inc.), 1500 South 1000 West, Logan, 

UT 84321 

NordicTrack, Inc., 1500 South 1000 

West, Logan, UT 84321 

Free Motion Fitness, Inc., 1500 South 

1000 West, Logan, UT 84321 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

The Office of Unfair Import 

Investigations will not be named as a 

party to this investigation. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondents in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainant of the 

complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of a respondent to file a timely 

response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

Issued: April 1, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–07355 Filed 4–6–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Pistoia Alliance, Inc. 

Notice is hereby given that, on 

December 8, 2021, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), 

Pistoia Alliance, Inc. has filed written 

notifications simultaneously with the 

Attorney General and the Federal Trade 


khammond on DSKJM1Z7X2PROD with NOTICES
20464 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Semalytix GmbH, 

Bielefeld, GERMANY; Schrodinger, 

Portland, NY; SAGE Therapeutics, 

Cambridge, MA; Rapid Novor, Waterloo, 

CANADA; Matador Japan KK, Nagano, 

JAPAN; Claire Bellamy (individual 

member), Leicestershire, UNITED 

KINGDOM; Chitrita Goswami 

(individual member), New Delhi, 

INDIA; Eurofins Discovery, St. Charles, 

MO; Centre for Process Innovation, 

Wilton, UNITED KINGDOM; and 

Artificial Inc., Palo Alto, CA have been 

added as parties to this venture. 

Also, WorldQuant Predictive, New 

York, NY; telic, New York, NY; 

Synthace Ltd, London, UNITED 

KINGDOM; Sapio Sciences, Baltimore, 

MD; PHEMI Systems Corp., Vancouver, 

CANADA; Mcule, Budapest, 

HUNGARY; GenAIz, Montreal, 

CANADA; and Apheris AI GmbH, 

Berlin, GERMANY have withdrawn as 

parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and Pistoia 

Alliance, Inc. intends to file additional 

written notifications disclosing all 

changes in membership. 

On May 28, 2009, Pistoia Alliance, 

Inc. filed its original notification 

pursuant to Section 6(a) of the Act. The 

Department of Justice published a notice 

in the Federal Register pursuant to 

Section 6(b) of the Act on July 15, 2009 

(74 FR 34364). 

The last notification was filed with 

the Department on September 12, 2021. 

A notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on October 5, 2021 (86 FR 55002). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2022–07339 Filed 4–6–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–988] 

Bulk Manufacturer of Controlled 

Substances Application: Purisys, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Purisys, LLC. has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTAL

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before June 6, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

June 6, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on January 21, 2022, 1550 

Olympic Drive, Athens, Georgia 30601– 

1602, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Cathinone .................................. 1235 I 

Gamma Hydroxybutyric Acid .... 2010 I 

Lysergic acid diethylamide ....... 7315 I 

Marihuana Extract ..................... 7350 I 

Marihuana ................................. 7360 I 

Tetrahydrocannabinols ............. 7370 I 

2,5-Dimethoxyamphetamine ..... 7396 I 

3,4-Methylenedioxy 

amphetamine. 

7400 I 

5-Methoxy-3,4-methylenedioxy 

amphetamine.

7401 I 

3,4-Methylenedioxy 

methamphetamine. 

7405 I 

5-Methoxy-N-N-dimethyl 

tryptamine. 

7431 I 

Diethyltryptamine ...................... 7434 I 

Dimethyltryptamine ................... 7435 I 

Psilocybin .................................. 7437 I 

Psilocyn ..................................... 7438 I 

Codeine-N-oxide ....................... 9053 I 

Dihydromorphine ....................... 9145 I 

Hydromorphinol ......................... 9301 I 

Morphine-N-oxide ..................... 9307 I 

Normorphine ............................. 9313 I 

Norlevorphanol .......................... 9634 I 

Codeine ..................................... 9050 II 

Dihydrocodeine ......................... 9120 II 

Oxycodone ................................ 9143 II 

Hydromorphone ........................ 9150 II 

Controlled substance Drug 

code Schedule 

Hydrocodone ............................. 9193 II 

Levorphanol .............................. 9220 II 

Morphine ................................... 9300 II 

Oripavine ................................... 9330 II 

Thebaine ................................... 9333 II 

Opium tincture .......................... 9630 II 

Opium, powdered ..................... 9639 II 

Opium, granulated .................... 9640 II 

Oxymorphone ........................... 9652 II 

Noroxymorphone ...................... 9668 II 

Alfentanil ................................... 9737 II 

Sufentanil .................................. 9740 II 

Carfentanil ................................. 9743 II 

Tapentadol ................................ 9780 II 

Fentanyl .................................... 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for internal use 

intermediates or for sale to its 

customers. The company plans to 

manufacture the above-listed controlled 

substances as clinical trial and starting 

materials to make compounds for 

distribution to its customers. No other 

activities for these drug codes are 

authorized for this registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–07368 Filed 4–6–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB 1140–0092] 

Agency Information Collection 

Activities; Proposed eCollection of 

eComments Requested; Voluntary 

Magazine Questionnaire for Agencies/ 

Entities That Store Explosive Materials 

AGENCY: Bureau of Alcohol, Tobacco, 

Firearms and Explosives, Department of 

Justice. 

ACTION: 60-Day notice. 

SUMMARY: The Bureau of Alcohol, 

Tobacco, Firearms and Explosives 

(ATF), Department of Justice (DOJ), will 

submit the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

The proposed information collection 

(IC) is also being published to obtain 

comments from the public and affected 

agencies. 

DATES: Comments are encouraged and 

will be accepted for 60 days until June 

6, 2022. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

regarding the estimated public burden 

or associated response time, 

suggestions, or need a copy of the 

proposed information collection 


khammond on DSKJM1Z7X2PROD with NOTICES